/index.php?option=com_iwpfile&file=/dir_01/he2002_2979.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2980.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2973.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2974.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2975.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2976.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_2977.pdf


The Subcommittee on Oversight and Investigations has scheduled a hearing for Wednesday, December 11, 2002, at 9:30 a.m., in 2123 Rayburn House Office Building. The title of the hearing is "Issues Relating to the Safety of Accutane." Witnesses will be by invitation only.

This hearing will be webcast live. For more information, please visit http://energycommerce.house.gov/107/hearings/12112002Hearing755/hearing.htm







Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.